logo

For the Inventor, By the Inventor

Plainsboro, NJ, United States of America

Young Woo Kim

This inventor holds 6 USPTO granted patents. Top assignees: Tanox Biosystems, Inc., Tanux Biosystems, Inc.. Active years: 1997-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young Woo Kim. Retrieved from https://idiyas.com/inventor/young-woo-kim-eo22h0jz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Plainsboro, NJ (US) (1997 - 1998)
  • Sugar Land, TX (US) (1998)

Company Filing History:

goldMedal5 out of 44 
 
Tanox Biosystems, Inc.
 patents
silverMedal1 out of 1 
 
Tanux Biosystems, Inc.
 patent

Years Active: 1997-1998

Loading Chart...
6 patents (USPTO):Explore Patents
1. 5834599 - Immunoconjugates which neutralize HIV-1 infection (1998-11-10),
2. 5739306 - gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides (1998-04-14),
3. 5731428 - gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides (1998-03-24),
4. 5728814 - GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides (1998-03-17),
5. 5691447 - GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides (1997-11-25),
6. 5652333 - gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides (1997-07-29),

Title: Innovations of Young Woo Kim

Introduction

Young Woo Kim is a prominent inventor based in Plainsboro, NJ (US), known for his significant contributions to the field of immunology. He holds a total of six patents, showcasing his innovative approach to combating viral infections, particularly HIV-1.

Latest Patents

Among his latest patents, Kim has developed immunoconjugates that neutralize HIV-1 infection. These monoclonal antibodies bind to the gp120 protein on the envelope of HIV-1, effectively neutralizing the virus. They inhibit the infection of T cells and prevent syncytium formation. Notably, these antibodies are group-specific and can neutralize various strains and isolates of HIV-1. Their applications extend to the treatment and prevention of AIDS and AIDS-related complex (ARC). Additionally, he has disclosed immunogens and peptides based on the binding site of the gC1q receptor for HIV-1 gp120. This includes antibodies and binding molecules that induce the endogenous production of such antibodies.

Career Highlights

Throughout his career, Young Woo Kim has worked with notable companies, including Tanox Biosystems, Inc. and Tanux Biosystems, Inc. His work has significantly advanced the understanding and treatment of HIV-1 infections.

Collaborations

Kim has collaborated with esteemed colleagues, including Michael S. Fung and Bill N. Sun, contributing to the development of innovative solutions in immunology.

Conclusion

Young Woo Kim's contributions to the field of immunology, particularly in the fight against HIV-1, highlight his role as a leading inventor. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…